Far-infrared rays enhance mitochondrial biogenesis and GLUT3 expression under low glucose conditions in rat skeletal muscle cells

• Published in: The Korean journal of physiology & pharmacology Vol. 25; no. 2; pp. 167 - 175
• Main Authors: Seo, Yelim, Kim, Young-Won, Lee, Donghee, Kim, Donghyeon, Kim, Kyoungseo, Kim, Taewoo, Baek, Changyeob, Lee, Yerim, Lee, Junhyeok, Lee, Hosung, Jang, Geonwoo, Jeong, Wonyeong, Choi, Junho, Hwang, Doegeun, Suh, Jung Soo, Kim, Sun-Woo, Kim, Hyoung Kyu, Han, Jin, Bang, Hyoweon, Kim, Jung-Ha, Zhou, Tong, Ko, Jae-Hong
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Physiological Society and The Korean Society of Pharmacology 01.03.2021; 대한약리학회
• Subjects: Original; 약리학; Infrared rays; Mitochondrial biogenesis; Glucose; Glucose transporter type 3; Radiation
• ISSN: 1226-4512; 2093-3827
• DOI: 10.4196/KJPP.2021.25.2.167

Far-infrared rays (FIR) are known to have various effects on atoms and molecular structures within cells owing to their radiation and vibration frequencies. The present study examined the effects of FIR on gene expression related to glucose transport through microarray analysis in rat skeletal muscle cells, as well as on mitochondrial biogenesis, at high and low glucose conditions. FIR were emitted from a bio-active material coated fabric (BMCF). L6 cells were treated with 30% BMCF for 24 h in medium containing 25 or 5.5 mM glucose, and changes in the expression of glucose transporter genes were determined. The expression of (Slc2a3) increased 2.0-fold (p < 0.05) under 5.5 mM glucose and 30% BMCF. In addition, mitochondrial oxygen consumption and membrane potential (ΔΨ ) increased 1.5- and 3.4-fold (p < 0.05 and p < 0.001), respectively, but no significant change in expression of , a regulator of mitochondrial biogenesis, was observed in 24 h. To analyze the relationship between expression and mitochondrial biogenesis under FIR, was down-modulated by siRNA for 72 h. As a result, the ΔΨ of the siRNA-treated cells increased 3.0-fold (p < 0.001), whereas that of the control group increased 4.6-fold (p < 0.001). Moreover, expression increased upon 30% BMCF treatment for 72 h; an effect that was more pronounced in the presence of . These results suggest that FIR may hold therapeutic potential for improving glucose metabolism and mitochondrial function in metabolic diseases associated with insufficient glucose supply, such as type 2 diabetes.